(NYSE: TFX) Teleflex's forecast annual revenue growth rate of 11.12% is forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 10.68%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.5%.
Teleflex's revenue in 2026 is $1,992,713,000.On average, 15 Wall Street analysts forecast TFX's revenue for 2026 to be $129,286,643,850, with the lowest TFX revenue forecast at $98,965,058,318, and the highest TFX revenue forecast at $170,525,768,196. On average, 13 Wall Street analysts forecast TFX's revenue for 2027 to be $134,281,307,356, with the lowest TFX revenue forecast at $103,738,719,014, and the highest TFX revenue forecast at $177,951,462,612.
In 2028, TFX is forecast to generate $112,667,232,538 in revenue, with the lowest revenue forecast at $108,556,580,272 and the highest revenue forecast at $118,369,105,036.